Cav3.1 Ca2+ Channel (AA 2052-2172), (C-Term) Antikörper
Kurzübersicht für Cav3.1 Ca2+ Channel (AA 2052-2172), (C-Term) Antikörper (ABIN1721485)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 2052-2172, C-Term
-
Spezifität
- Reacts withhuman, mouse, and rat Cav3.1. Does not cross-react with Cav3.2.
-
Aufreinigung
- Purified
-
Immunogen
- Fusion protein corresponding to aa 2052-2172 (cytoplasmic C-terminus) of mouse Cav3.1 (accession no. NP_001106284.1).
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(1 - 2 μg/mL) IHC(1 - 10 μg/mL)
Positive control: Rat brain membranes -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4, 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Dilute in PBS or medium that is identical to that used in the assay system.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Cav3.1 Ca2+ Channel
-
Hintergrund
-
Ion channels are integral membrane proteins that help establish and control the small voltage gradient across the plasma membrane of living cells by allowing the flow of ions down their electrochemical gradient. Cav3.1 is a low-voltage activated T-type calcium channel expressed throughout the body. Drugs that block T-type calcium channels are used as antihypertensives and anti-epileptics and possibly in some anesthetics and antipsychotics.
Voltage-dependent T-type calcium channel subunit alpha-1G Cav3.1c NBR13 Voltage-gated calcium channel subunit alpha Cav3.1 Gene name: CACNA1G, KIAA1123 Ca(V)T.1, Cav3.1, NBR13 -
Gen-ID
- 8913
-
UniProt
- O43497
Target
-